Uncategorised - European Medical Journal

A New Pain Self-Management Intervention Tailored to People with HIV

Research has demonstrated that the STOMP behavioural pain self-management intervention significantly reduces pain severity and the impact of pain on function in people with HIV.

Elon Musk's Neuralink inserts brain implant into second patient

Elon Musk’s Neuralink has implanted its brain implant into a new patient, making them the second person to take part in the trial.

Taking control of customer experience

The team explores how the industry may be missing out on insights from HCPs and hears from Robert Tegge, Associate Principal, ZS, who shares valuable insights on congresses.

Long-Term Immune Changes in Unvaccinated Patients with COVID-19

A study from Vienna reveals persistent immune changes, including shifts in cell counts and cytokine profiles, up to 10 months post-COVID-19 infection

Plant-Based Diets Uncover Rising Legume Allergies

Allergies to non-priority legumes like beans and chickpeas are increasing with the rise in plant-based diets. A new review highlights the need for more research on these allergens.

Interview: Michael Camilleri

One of the wonderful opportunities I’ve had over the years is to interact and go across specialties, divisions, or departments. Here at Mayo Clinic, there’s a wonderful legacy of cross-disciplinary research…

ESHRE 2024 Interview: Karen Sermon

I went to medical school in Brussels, but I knew very early on that I didn’t want to practice, I wanted to go into research. So, I looked…

Spotlight: July 2024

Catch up on the top pharma news stories of July in EMJ GOLD’s monthly round-up, including insights on pharma’s use of social media.

Normoxia Doesn't Rule Out Hypercapnia in Patients with Neuromuscular Disease

A study found that normal oximetry cannot rule out hypercapnia in neuromuscular disease patients. New diagnostic approaches are crucial for accurate detection and intervention.

Long-Term Lung Damage Persists in COVID-19 Survivors

A recent study shows many COVID-19 survivors have lasting lung issues and reduced pulmonary function three years post-hospitalization, highlighting the need for ongoing care.